| scholarly article | Q13442814 |
| P2093 | author name string | F. C. Brosius | |
| Z. Lin | |||
| M. T. Crow | |||
| G. Núñez | |||
| D. Ekhterae | |||
| M. S. Lundberg | |||
| P433 | issue | 12 | |
| P921 | main subject | mitochondrion | Q39572 |
| apoptotic process | Q14599311 | ||
| hypoxia | Q105688 | ||
| P304 | page(s) | e70–77 | |
| P577 | publication date | 1999-12-09 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | ARC inhibits cytochrome c release from mitochondria and protects against hypoxia-induced apoptosis in heart-derived H9c2 cells | |
| P478 | volume | 85 |
| Q39607665 | 17Beta-estradiol regulates expression of K(ATP) channels in heart-derived H9c2 cells |
| Q28513703 | A critical role for the protein apoptosis repressor with caspase recruitment domain in hypoxia-induced pulmonary hypertension |
| Q39858392 | A dual mechanism of cytoprotection afforded by M-LDH in embryonic heart H9C2 cells |
| Q40687709 | A novel nonpeptidic caspase-3/7 inhibitor, (S)-(+)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injury |
| Q28578490 | ARC protects rat cardiomyocytes against oxidative stress through inhibition of caspase-2 mediated mitochondrial pathway |
| Q58618081 | ARC regulates programmed necrosis and myocardial ischemia/reperfusion injury through the inhibition of mPTP opening |
| Q53859301 | ARC, an apoptosis suppressor limited to terminally differentiated cells, is induced in human breast cancer and confers chemo- and radiation-resistance. |
| Q38999390 | Activation of Akt by SC79 protects myocardiocytes from oxygen and glucose deprivation (OGD)/re-oxygenation |
| Q35600688 | Activation of K+ channels: an essential pathway in programmed cell death |
| Q36274429 | Activation of SphK1 by K6PC-5 Inhibits Oxygen-Glucose Deprivation/Reoxygenation-Induced Myocardial Cell Death |
| Q34240639 | Apoptosis and syncytial fusion in human placental trophoblast and skeletal muscle |
| Q34021169 | Apoptosis in Cardiovascular Diseases: Mechanism and Clinical Implications |
| Q35119665 | Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases |
| Q37939582 | Apoptosis in skeletal myocytes: a potential target for interventions against sarcopenia and physical frailty - a mini-review |
| Q28511114 | Apoptosis repressor with a CARD domain (ARC) restrains Bax-mediated pathogenesis in dystrophic skeletal muscle |
| Q34195169 | Apoptosis repressor with caspase domain inhibits cardiomyocyte apoptosis by reducing K+ currents |
| Q98282741 | Apoptosis repressor with caspase recruitment domain promotes cell proliferation and phenotypic modulation through 14-3-3ε/YAP signaling in vascular smooth muscle cells |
| Q24314624 | Apoptosis repressor with caspase recruitment domain protects against cell death by interfering with Bax activation |
| Q37294049 | Apoptosis repressor with caspase recruitment domain, a multifunctional modulator of cell death |
| Q35879493 | Apoptosome formation and caspase activation: is it different in the heart? |
| Q37263689 | Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling |
| Q33580128 | Autophagic program is regulated by miR-325 |
| Q38948751 | Beneficial properties of selenium incorporated guar gum nanoparticles against ischemia/reperfusion in cardiomyoblasts (H9c2). |
| Q44512374 | Biochemical processing of E-cadherin under cellular stress |
| Q64377569 | Blocking the development of postischemic cardiomyopathy with viral gene transfer of the apoptosis repressor with caspase recruitment domain |
| Q36520325 | Bone marrow-derived mesenchymal stem cells rescue injured H9c2 cells via transferring intact mitochondria through tunneling nanotubes in an in vitro simulated ischemia/reperfusion model |
| Q24309652 | Calcium binding of ARC mediates regulation of caspase 8 and cell death |
| Q39976439 | Caspase-8 and its inhibitors in RCCs in vivo: the prominent role of ARC. |
| Q34490918 | Cell death in the heart |
| Q34609532 | Cell death-resistance of differentiated myotubes is associated with enhanced anti-apoptotic mechanisms compared to myoblasts |
| Q24681327 | Chronic mild hypoxia protects heart-derived H9c2 cells against acute hypoxia/reoxygenation by regulating expression of the SUR2A subunit of the ATP-sensitive K+ channel |
| Q34490973 | Death receptors and apoptosis. Deadly signaling and evasive tactics |
| Q43499688 | Differential apoptosis-related protein expression, mitochondrial properties, proteolytic enzyme activity, and DNA fragmentation between skeletal muscles |
| Q36275682 | Don't lose heart--therapeutic value of apoptosis prevention in the treatment of cardiovascular disease. |
| Q28568811 | Down-regulation of ARC contributes to vulnerability of hippocampal neurons to ischemia/hypoxia |
| Q37457656 | Down-regulation of microRNA-320 suppresses cardiomyocyte apoptosis and protects against myocardial ischemia and reperfusion injury by targeting IGF-1. |
| Q37690905 | Effects of the Activin A-Follistatin System on Myocardial Cell Apoptosis through the Endoplasmic Reticulum Stress Pathway in Heart Failure |
| Q74460269 | Endogenous and exogenous ARC in serum withdrawal mediated PC12 cell apoptosis: a new pro-apoptotic role for ARC |
| Q44117700 | Enhanced glycogen synthase kinase-3beta activity mediates hypoxia-induced apoptosis of vascular smooth muscle cells and is prevented by glucose transport and metabolism |
| Q34580411 | Exogenous ARC down-regulates caspase-3 expression and inhibits apoptosis of broiler chicken cardiomyocytes exposed to hydrogen peroxide |
| Q40028642 | Expression and modification of ARC (apoptosis repressor with a CARD domain) is distinctly regulated by oxidative stress in cancer cells |
| Q42471596 | Functional, morphological, and apoptotic alterations in skeletal muscle of ARC deficient mice. |
| Q40670845 | H9c2 cardiac myoblasts undergo apoptosis in a model of ischemia consisting of serum deprivation and hypoxia: inhibition by PMA. |
| Q33223963 | Heat shock pretreatment inhibited the release of Smac/DIABLO from mitochondria and apoptosis induced by hydrogen peroxide in cardiomyocytes and C2C12 myogenic cells |
| Q40810018 | Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death. |
| Q44654247 | Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro |
| Q28564545 | Hypoxia predisposes neonatal rat ventricular myocytes to apoptosis induced by activation of the Fas (CD95/Apo-1) receptor: Fas activation and apoptosis in hypoxic myocytes |
| Q42240623 | Imperatorin protects H9c2 cardiomyoblasts cells from hypoxia/reoxygenation-induced injury through activation of ERK signaling pathway |
| Q37280058 | Infarction induced myocardial apoptosis and ARC activation |
| Q35626056 | Ins and outs of apoptosis in cardiovascular diseases |
| Q34544863 | Intracellular function of interleukin-1 receptor antagonist in ischemic cardiomyocytes |
| Q42068594 | Isoflurane reduces oxygen-glucose deprivation-induced oxidative, inflammatory, and apoptotic responses in H9c2 cardiomyocytes |
| Q36473830 | K+ channels in apoptosis |
| Q39285198 | Knockdown of apoptosis repressor with caspase recruitment domain (ARC) increases the sensitivity of human glioma cell line U251MG to VM-26. |
| Q90658772 | Long noncoding RNA PCAT6 inhibits colon cancer cell apoptosis by regulating anti-apoptotic protein ARC expression via EZH2 |
| Q35697472 | Mechanisms of apoptosis in the heart |
| Q34541619 | MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy |
| Q35274471 | MicroRNA-532-3p regulates mitochondrial fission through targeting apoptosis repressor with caspase recruitment domain in doxorubicin cardiotoxicity |
| Q35111011 | MicroRNA-7a/b protects against cardiac myocyte injury in ischemia/reperfusion by targeting poly(ADP-ribose) polymerase |
| Q35111543 | Mitochondria in apoptosis of ischemic heart |
| Q40697544 | Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis |
| Q46063605 | Mitochondrial fission leads to Smac/DIABLO release quenched by ARC. |
| Q44506171 | Mitochondrial permeability transition and cytochrome c release in ischemia-reperfusion injury of the rat liver |
| Q45222439 | Modulation of endothelin-A receptor, Galpha subunit, and RGS2 expression during H9c2 cardiomyoblast differentiation. |
| Q43263729 | Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes |
| Q54642083 | Neuroprotection Induced In Vitro by Ischemic Preconditioning and Postconditioning: Modulation of Apoptosis and PI3K–Akt Pathways |
| Q47700020 | Nuclear poly(A) binding protein 1 (PABPN1) and Matrin3 interact in muscle cells and regulate RNA processing |
| Q33624309 | Overexpression of Exosomal Cardioprotective miRNAs Mitigates Hypoxia-Induced H9c2 Cells Apoptosis |
| Q33883415 | PEDF and PEDF-derived peptide 44mer protect cardiomyocytes against hypoxia-induced apoptosis and necroptosis via anti-oxidative effect |
| Q24300092 | Prolyl hydroxylase 3 interacts with Bcl-2 to regulate doxorubicin-induced apoptosis in H9c2 cells |
| Q28589642 | Protection of cardiomyocytes from ischemic/hypoxic cell death via Drbp1 and pMe2GlyDH in cardio-specific ARC transgenic mice |
| Q35063194 | Regulation of cardiac myocyte cell death |
| Q40629432 | Regulation of necrosis of H9c2 myogenic cells upon transient energy deprivation. Rapid deenergization of mitochondria precedes necrosis and is controlled by reactive oxygen species, stress kinase JNK, HSP72 and ARC. |
| Q91584504 | Role of apoptosis repressor with caspase recruitment domain (ARC) in cancer |
| Q33840730 | Sex-related resistance to myocardial ischemia-reperfusion injury is associated with high constitutive ARC expression |
| Q33182142 | Signal transduction of nitric oxide donor-induced protection in hydrogen peroxide-mediated apoptosis in H9C2 cardiomyoblasts |
| Q43273844 | Sildenafil decreased cardiac cell apoptosis in diabetic mice: reduction of oxidative stress as a possible mechanism. |
| Q36687399 | Steroidal Saponin Diosgenin from Dioscorea bulbifera Protects Cardiac Cells from Hypoxia-reoxygenation Injury Through Modulation of Pro-survival and Pro-death Molecules |
| Q34558163 | TanshinoneIIA and cryptotanshinone protect against hypoxia-induced mitochondrial apoptosis in H9c2 cells |
| Q24322401 | The apoptosis inhibitor ARC undergoes ubiquitin-proteasomal-mediated degradation in response to death stimuli: identification of a degradation-resistant mutant |
| Q41908755 | The apoptosis repressor with a CARD domain (ARC) gene is a direct hypoxia-inducible factor 1 target gene and promotes survival and proliferation of VHL-deficient renal cancer cells |
| Q40794732 | The apoptotic regulatory protein ARC (apoptosis repressor with caspase recruitment domain) prevents oxidant stress-mediated cell death by preserving mitochondrial function |
| Q44298840 | The cardioprotective effect of postconditioning is mediated by ARC through inhibiting mitochondrial apoptotic pathway |
| Q36172441 | The role of apoptosis in age-related skeletal muscle atrophy |
| Q28565157 | Transcription factor Foxo3a prevents apoptosis by regulating calcium through the apoptosis repressor with caspase recruitment domain |
| Q28569720 | p53 initiates apoptosis by transcriptionally targeting the antiapoptotic protein ARC |
Search more.